Interact to see
Advertisement
Advertisement
SLMCX vs USSCX
SLMCX vs USSCX Comparison
Open Charts SLMCX vs USSCX
SLMCX vs USSCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
SLMCX vs. USSCX commentary
Aug 17, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLMCX is a Buy and USSCX is a Buy.
FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 29.7B vs. USSCX (1.63B). SLMCX (0.00) and USSCX (0.00) have matching dividends . SLMCX was incepted earlier than USSCX: SLMCX (43 years) vs USSCX (29 years). SLMCX (1.16) is less costly to investors than USSCX (0.96). SLMCX is a more actively managed with annual turnover of: 33.00 vs. USSCX (31.00). SLMCX has a lower initial minimum investment than USSCX: SLMCX (2000) vs USSCX (3000). SLMCX annual gain was more profitable for investors over the last year : 71.97 vs. USSCX (23.86). SLMCX return over 5 years is better than : 94.03 vs. USSCX (14.56).
| SLMCX | USSCX | SLMCX / USSCX | |
| Total Expense Ratio | 1.16 | 0.96 | 121% |
| Annual Report Gross Expense Ratio | 1.16 | 0.96 | 121% |
| Fund Existence | 43 years | 29 years | - |
| Gain YTD | 57.428 | 25.632 | 224% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 3000 | 67% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 29.7B | 1.63B | 1,823% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 71.97 | 23.86 | 302% |
| Returns for 3 years | 137.07 | 97.13 | 141% |
| Returns for 5 years | 94.03 | 14.56 | 646% |
| Returns for 10 years | 316.21 | 84.59 | 374% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FTXCX | 66.48 | 0.51 | +0.77% |
| FullerThaler Behavioral Sm-Cp Gr C | |||
| RPGIX | 27.13 | 0.02 | +0.07% |
| T. Rowe Price Global Industrials | |||
| PHLQX | 52.73 | -0.03 | -0.06% |
| PGIM Jennison Health Sciences R6 | |||
| PAGHX | 147.34 | -0.75 | -0.51% |
| Permanent Portfolio Aggressive Growth C | |||
| RICGX | 70.50 | -0.51 | -0.72% |
| American Funds Invmt Co of Amer R-6 | |||